Answers are grounded in this paper and cite their sources.
Here, we describe the development and disseminate system methods for associating patient genomic sequence data with clinically relevant information, facilitating interpretation and providing a mechanism for informing therapeutic decision-making. Additionally, through customized queries, we have the capability to rapidly analyze the landscape of targeted therapies in clinical trials, enabling a unique view into current therapeutic availability in oncology.
No takes yet. Share an insight, caveat, or question.
Patterson et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: